scholarly article | Q13442814 |
P2093 | author name string | Riccio A | |
Danø K | |||
Blasi F | |||
Andreasen PA | |||
Lania A | |||
Sartorio R | |||
Lund LR | |||
P2860 | cites work | Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution | Q24604324 |
A new method for sequencing DNA | Q24605576 | ||
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors | Q26778475 | ||
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta | Q28288182 | ||
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor | Q28288345 | ||
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements | Q28288355 | ||
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937 | Q28647070 | ||
Lambda replacement vectors carrying polylinker sequences | Q29616529 | ||
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene | Q29618347 | ||
Establishment and characterization of a human histiocytic lymphoma cell line (U-937) | Q29619570 | ||
Transformation of mammalian cells with genes from procaryotes and eucaryotes | Q34030262 | ||
The chemistry and biology of left-handed Z-DNA. | Q34055568 | ||
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. | Q34278348 | ||
Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. | Q34534987 | ||
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells | Q34551601 | ||
Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family | Q35059478 | ||
Sequence analysis of a KpnI family member near the 3' end of human beta-globin gene | Q35563750 | ||
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity | Q35599380 | ||
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta | Q36216679 | ||
Some recent advances in the chemistry and biology of transforming growth factor-beta | Q36217584 | ||
Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns | Q36282047 | ||
A novel repeated element with Z-DNA-forming potential is widely found in evolutionarily diverse eukaryotic genomes | Q36317993 | ||
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection | Q36320006 | ||
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor | Q36351900 | ||
cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell | Q36426170 | ||
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor | Q36430764 | ||
The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains | Q36586759 | ||
pEMBL: a new family of single stranded plasmids | Q36597299 | ||
Glucocorticoids enhance stability of human growth hormone mRNA. | Q36838875 | ||
Nucleotide sequences required for the regulation of a rat alpha 2u-globulin gene by glucocorticoids | Q36916843 | ||
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells. | Q36920255 | ||
Unusual class of Alu sequences containing a potential Z-DNA segment | Q36939228 | ||
Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets | Q37575727 | ||
Plasminogen activators, tissue degradation, and cancer | Q39476382 | ||
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors | Q39508019 | ||
Plasminogen activator inhibitors | Q39592746 | ||
Revision of consensus sequence of human Alu repeats--a review | Q39774353 | ||
Tumor promoters: Effects on proliferation and differentiation of cells in culture | Q39780861 | ||
Steroid receptor regulated transcription of specific genes and gene networks | Q39838638 | ||
cDNA and gene nucleotide sequence of porcine plasminogen activator. | Q40463453 | ||
The human urokinase-plasminogen activator gene and its promoter. | Q40568749 | ||
Negative control of liver-specific gene expression: cloned human retinol-binding protein gene is repressed in HeLa cells. | Q41335262 | ||
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts | Q41362675 | ||
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication | Q41762670 | ||
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblasts | Q42460968 | ||
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix | Q43755354 | ||
Specific induction of secreted proteins by transforming growth factor-beta and 12-O-tetradecanoylphorbol-13-acetate. Relationship with an inhibitor of plasminogen activator. | Q44562849 | ||
Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. | Q46198950 | ||
Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. | Q48354717 | ||
Structure of wild-type and mutant mouse β2-microglobulin genes | Q48404514 | ||
Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies. | Q50909761 | ||
Characteristics of interactions between surfactants and the human erythrocyte membrane | Q52997725 | ||
Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells. | Q54422451 | ||
Hormonal regulation of plasminogen activator in rat hepatoma cells | Q54507310 | ||
A cyclic AMP- and phorbol ester-inducible DNA element | Q59069805 | ||
Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells | Q68823705 | ||
Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification | Q68881157 | ||
Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells | Q69989081 | ||
Subunit structure of a high-affinity receptor for type beta-transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complex | Q70086167 | ||
Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine | Q70316527 | ||
Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts | Q72389967 | ||
P433 | issue | 7 | |
P304 | page(s) | 2805-2824 | |
P577 | publication date | 1988-04-01 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene | |
P478 | volume | 16 |
Q72053143 | A nuclear post-transcriptional mechanism mediates the induction of fibronectin by glucocorticoids |
Q40395907 | Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53 |
Q36768116 | Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation |
Q28291444 | Exogenous estrogen may exacerbate thrombophilia, impair bone healing and contribute to development of chronic facial pain |
Q44833434 | Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP |
Q41724641 | Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells |
Q22010204 | Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 gene |
Q59101064 | Functional stability of plasminogen activator inhibitor-1 |
Q40582647 | Genetic determinants of arterial thrombosis |
Q71037723 | Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells |
Q43594124 | Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells |
Q41584835 | Molecular organization of the rat glia-derived nexin/protease nexin-1 promoter. |
Q71718204 | Pathophysiology of fibrinolysis |
Q45136856 | Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma |
Q39584815 | Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1 |
Q36626366 | The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease |
Q40530719 | Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor |
Q40678620 | Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene |
Q47744629 | Transforming growth factor-ßs as modulators of pericellular proteolytic events |
Q41083036 | Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells |
Search more.